Amazon Pharmacy starts offering Wegovy weight-loss pill

Novo Nordisk's oral Wegovy pill is now available on Amazon Pharmacy in the U.S., with a cash price starting at $149 per month and insured patients able to pay as little as $25.

Novo Nordisk began rolling out an oral version of its injectable obesity drug Wegovy in the United States this week. Amazon Pharmacy is offering the pill, listing a cash price of $149 per month for the starting dose and saying insured customers can pay as little as $25 for a one-month supply. Amazon also plans to distribute the pill through prescription vending kiosks in select One Medical clinics in the coming weeks. The pill is being made available across pharmacies and some telehealth providers as part of the broader launch. Key details: - Novo Nordisk began a U.S. rollout of an oral Wegovy pill, with a starting cash price of $149 per month and insured patients able to pay as little as $25 for a one-month supply. - Amazon Pharmacy will offer the pill and said it will provide it through prescription vending kiosks at select One Medical clinics in the coming weeks. - The product is also available at more than 70,000 U.S. pharmacies, including CVS and Costco, and through telehealth providers such as Ro, LifeMD, Weight Watchers, GoodRx and NovoCare Pharmacy. - Amazon Pharmacy was launched after Amazon's acquisition of PillPack and later One Medical; the company highlights same-day prescription delivery for many U.S. consumers. - Cash-paying patients can also access the starting dose through TrumpRx under a deal Novo Nordisk reached with the administration; the site’s launch timing in January is unclear. - Health experts reported that oral options could expand access to obesity treatment, and Eli Lilly has a rival obesity pill slated to win FDA approval later this year. Summary: The rollout places an oral form of Wegovy into multiple U.S. distribution channels, with listed cash and insured prices for the initial dose. Amazon’s pharmacy and kiosk plans add another route for distribution, while availability at thousands of pharmacies and telehealth providers broadens where the pill can be obtained. How quickly patients will use the new oral option and the longer-term effects on the market are undetermined at this time.